Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AST-Guided vs Empirical Therapy for H. pylori
NCT03571230Phase 4Unknown
- Sponsor
- Shandong University
- Start
- Jul 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of amoxicillin, clarithromycin, metronidazole, tinidazole, levofloxacin and 2 more in Helicobacter pylori infection (2 arms), sponsored by Shandong University. Primary endpoint: Eradication rates in 2 groups at 6 months. Status: unknown.
02
Drugs
amoxicillinclarithromycinmetronidazoletinidazolelevofloxacin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT03571230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03571230.